CARAMANTI, MIRIAM
 Distribuzione geografica
Continente #
NA - Nord America 416
EU - Europa 239
AS - Asia 97
AF - Africa 20
SA - Sud America 10
Totale 782
Nazione #
US - Stati Uniti d'America 416
IT - Italia 63
UA - Ucraina 40
SE - Svezia 36
CN - Cina 25
RU - Federazione Russa 25
TR - Turchia 25
SG - Singapore 24
IE - Irlanda 23
DE - Germania 21
CI - Costa d'Avorio 17
DK - Danimarca 15
HK - Hong Kong 13
BR - Brasile 10
FI - Finlandia 9
KR - Corea 8
GB - Regno Unito 4
MA - Marocco 3
FR - Francia 2
IN - India 2
PT - Portogallo 1
Totale 782
Città #
Chandler 70
Jacksonville 42
Ashburn 34
Fairfield 34
Boardman 23
Dublin 23
New York 20
Seattle 19
Centro 18
Abidjan 17
Houston 15
Wilmington 15
Des Moines 14
Singapore 14
Hong Kong 13
Cambridge 10
Porto 10
Lawrence 9
Princeton 9
Woodbridge 9
San Mateo 8
Turin 6
Beijing 5
Chiaravalle 5
Guangzhou 5
San Diego 5
Washington 5
Ann Arbor 4
The Dalles 4
Los Angeles 3
Moscow 3
Ancona 2
Dallas 2
Rome 2
San Francisco 2
Segrate 2
São Paulo 2
Ankara 1
Arqua Petrarca 1
Baoding 1
Birmingham 1
Catalão 1
Cerquilho 1
Chennai 1
Chiswick 1
Fayetteville 1
Guarulhos 1
Helsinki 1
Jequié 1
Kilburn 1
Lisbon 1
Manaus 1
Marche 1
Munich 1
Norwalk 1
Porto Alegre 1
Prescot 1
Pune 1
Salvador 1
Suzhou 1
São José 1
Tolentino 1
Trecastelli 1
Urbisaglia 1
Weihai 1
Wuxi 1
Xi'an 1
Totale 513
Nome #
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 116
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 113
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 103
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. 96
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 89
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 82
IMPACT OF VEGF, VEGFR, PDGFR, HIF AND ERCC1 GENE POLYMORPHISMS ON THYMIC MALIGNANCIES OUTCOME 79
Hedgehog (Hh) Signaling is a Predictor of Clinical Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC). 73
Treatment of advanced small cell lung cancer 59
Totale 810
Categoria #
all - tutte 4.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 0 0 0 0 2 10
2020/2021151 7 11 37 1 14 7 11 9 14 20 16 4
2021/202261 6 12 0 2 0 6 1 3 5 8 5 13
2022/2023178 11 28 12 15 12 33 0 4 39 1 18 5
2023/2024110 13 3 7 11 16 35 1 6 3 2 1 12
2024/2025136 33 15 3 2 13 5 6 3 32 11 13 0
Totale 810